Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected stock price increase of over 15% relative to the industry index in the next six months [4][16]. Core Insights - The company has demonstrated strong revenue growth, with a reported revenue of 3.18 billion yuan in H1 2025, representing a year-on-year increase of 40.0%. The net profit attributable to the parent company reached 489 million yuan, up 117.8% year-on-year [1][2]. - The new products SUGO and TopTop have shown exceptional performance, with SUGO's revenue growth exceeding 100% and profit growth over 150%. TopTop also reported similar growth rates, benefiting from a strong market position in the Middle East and North Africa [2]. - The company is leveraging AI technology to enhance its social business, improving operational efficiency and user engagement metrics such as online duration and payment rates [2][3]. Financial Summary - The company is projected to achieve revenues of 6.98 billion yuan, 8.65 billion yuan, and 10.36 billion yuan for the years 2025, 2026, and 2027, respectively, with corresponding net profits of 951 million yuan, 1.23 billion yuan, and 1.53 billion yuan [1][3]. - Key financial metrics include a projected P/E ratio decreasing from 15.9 in 2025 to 9.9 in 2027, and a P/B ratio decreasing from 6.1 to 2.9 over the same period [1][3]. - The company’s return on equity (ROE) is expected to decline from 38.5% in 2025 to 29.7% in 2027, indicating a potential shift in profitability dynamics [1][3].

Group 1 - The Hang Seng Index fell by 0.4%, while the Hang Seng Tech Index decreased by 0.54%, with a total turnover of 152 billion HKD in the Hong Kong stock market during the morning session [1] - The Hang Seng Biotechnology Index rose by 1%, with notable gains from companies such as MicroPort Scientific Corporation (02252) up by 10%, and Four Seasons Medicine (00460) up by 8% [1] Group 2 - MicroPort Scientific Corporation (02252) saw a rise of over 10%, indicating renewed interest in the robotics industry and steady progress in the company's commercialization efforts [2] - Dongyang Sunshine Pharmaceutical (06887) increased by nearly 7%, reporting a mid-term gross profit of 1.468 billion HKD, with key data on Ifenprodil presented at the US IPF summit [2] - Chuangsheng Group-B (06628) surged over 28%, with a mid-term net loss narrowing by 17.9%, and TST001 research data making its debut at ASCO [2] - Kingsoft Holdings (03918) rose by over 6%, with first-half performance exceeding market expectations, although uncertainties remain regarding the Naga3 project according to Citigroup [2] - Green Power Environmental (01330) increased by over 7%, with a 24.49% year-on-year increase in net profit attributable to shareholders, driven by its gas supply business [2] - Hylink Technology (01860) rose by 7.9%, with first-half revenue increasing by 40% year-on-year, and institutions optimistic about the continued release of the Mintegral platform's flywheel effect [2] - Zhi Zi Cheng Technology (09911) rose by over 6%, with first-half net profit nearly doubling, and the group's gross profit margin expected to improve significantly year-on-year [2] - Four Seasons Medicine (00460) rose by over 7%, achieving profitability in the first half and making substantial progress in its AI + medical beauty strategic layout [2] - Guofu Quantum (00290) increased by 6.86%, with a cumulative increase of nearly 1.8 times this year, collaborating with Huajian Medical to advance RWA ecosystem construction [2] - New Idea Network Group (01686) fell by over 17% post-results, with annual net profit increasing by 8% to 979 million HKD [2]

Core Viewpoint - ZhiZi City Technology (09911) has shown significant stock performance, with a rise of over 7% and a current price of 12.4 HKD, reflecting strong market interest following its mid-year earnings report [1] Financial Performance - The company reported a 40.0% year-on-year increase in revenue for the first half of the year, with net profit attributable to shareholders soaring by 117.8% [1] - The gross profit margin reached 56%, an increase of 6 percentage points, attributed to a decrease in revenue sharing from social business and a higher proportion of high-margin innovative business [1] Market Performance - The Middle East and North Africa (MENA) market has been particularly strong, with revenue from core products in the region growing by over 60% year-on-year [1] - The continuous growth in the MENA region indicates that the company's localized operations are beginning to show a "compound effect," with increasing market barriers [1] Strategic Goals - ZhiZi City Technology is making steady progress towards its strategic goal of penetrating the Middle Eastern market, with several products leading in their respective segments [1] - The company plans to enhance its capabilities in product research and development, growth, and operations through centralized integration and AI empowerment, which is expected to gradually release operational leverage [1]

Core Viewpoint - Zhi Zi Cheng Technology (09911) has shown significant stock performance, with a recent increase of over 7%, currently trading at 12.4 HKD, reflecting a trading volume of 67.73 million HKD. The company reported a 40.0% year-on-year revenue growth and a substantial 117.8% increase in net profit attributable to shareholders for the first half of the year, particularly driven by strong performance in the Middle East and North Africa (MENA) region [1][1][1]. Financial Performance - The company achieved a gross margin of 56% in the first half of the year, an increase of 6 percentage points, attributed to a decrease in revenue sharing from social business and a higher proportion of high-margin innovative business [1][1]. - The revenue from core products in the MENA region grew by over 60% year-on-year, indicating the effectiveness of localized operations and the deepening of market barriers [1][1]. Strategic Outlook - The continuous growth in the MENA region suggests that the company's localization strategy is beginning to show a "compound effect," with the company making steady progress towards its strategic goal of penetrating the Middle Eastern market [1][1]. - Despite expected high marketing costs for new products in the short term, the company plans to enhance its capabilities in product research and development, growth, and operations through centralized integration and AI empowerment, which is anticipated to gradually release operational leverage in R&D and administrative expenses [1][1].

Core Viewpoint - The recent "Best IR in Hong Kong" award was given to ZhiZi Cheng Technology (09911.HK) for its excellence in investor relations management, highlighting its commitment to compliance, transparency, and effective communication with stakeholders [3]. Group 1: Award and Recognition - ZhiZi Cheng Technology won the "Best IR in Hong Kong" award in the "2025 New Fortune Magazine Best Secretary and Best IR in Hong Kong" selection [3]. - The selection process involved 5,267 A/B share companies and 2,464 Hong Kong listed companies, with participation from nearly 3,500 institutions and over 200,000 capital market professionals [3]. Group 2: Investor Relations Practices - The company adheres to principles of compliance, objectivity, and transparency in information disclosure, establishing strong communication channels with shareholders, investors, and regulators [3]. - ZhiZi Cheng Technology utilizes various formats such as earnings calls, online roadshows, and investor Q&A sessions to effectively communicate its latest developments and strategic vision [3]. Group 3: Financial Performance - For the first half of the year, ZhiZi Cheng Technology reported revenue of 3.181 billion yuan, a year-on-year increase of 40%, and a net profit attributable to shareholders of 489 million yuan, up 117.8% [4]. - The company’s social and innovative business segments are experiencing rapid growth, attracting attention from major securities firms [4]. Group 4: Market Position and Index Inclusion - ZhiZi Cheng Technology has been included in the FTSE Global Small Cap Index and the FTSE All-Cap Index, enhancing its market presence [4]. - The company was also added to the MSCI Global Small Cap Index earlier this year, indicating its growing influence in the capital market [4].

Core Viewpoint - Zhaizi City Technology (09911) has seen its stock price increase by 231% year-to-date, with a current valuation of 10 times the next 12 months' earnings and a PEG ratio of 0.5, compared to the industry averages of 16.5 times and 1.2 times in China, and 24 times and 1.5 times in the US [1] Financial Performance - The company's revenue for the first half of the year grew by 40% year-on-year, reaching 3.18 billion RMB, which met expectations [1] - Revenue from social and innovative businesses increased by 37% and 72% year-on-year, respectively [1] - Gross profit rose by 56% year-on-year, exceeding expectations by 10%, with a gross margin of 55.8%, an increase of 5.6 percentage points [1] - The gross margin for the innovative business significantly improved from 55% to 74%, driven by contributions from "Alice's Adventures" [1] - The gross margin for the social business increased by 3.8 percentage points to 54% year-on-year [1] Profitability Metrics - Adjusted operating profit and net profit grew by 51% and 137% year-on-year, respectively, surpassing expectations by 13% and 23% [1] - The strong performance is attributed to prudent cost control, operational leverage, and minority equity acquisitions [1] Target Price and Rating - The target price for Zhaizi City Technology has been raised from 12.2 HKD to 16.2 HKD, corresponding to 17 times and 14 times earnings for the fiscal years 2025 and 2026, respectively [1] - The company maintains a "buy" rating [1]

Core Points - Chen Yuyu has been appointed as an independent non-executive director of Zhi Zi Cheng Technology Co., Ltd., effective from August 29, 2025 [2] - Chen Yuyu will also serve as a member of the Audit Committee and the Compensation Committee upon joining the board [2] Group 1: Background of Chen Yuyu - Chen Yuyu is currently a professor at Peking University's Guanghua School of Management and the director of the Economic Policy Research Institute [3] - He has received several prestigious awards, including the National Natural Science Foundation's Distinguished Young Scholar Award in 2014 and the Changjiang Scholar Award from the Ministry of Education in 2017 [3] - Chen holds a Ph.D. in Economics from the Australian National University, obtained in 2002 [3] Group 2: Previous Board Experience - Chen has served as an independent director at Guangdong Xinhui Meida Nylon Co., Ltd. from June 2017 to January 2024 [2] - He was an independent director at Zhanjiang Guolian Aquatic Products Development Co., Ltd. from November 2019 to January 2021 [2] - Chen also held the position of independent director at Meizhou Ke Shang Bank Co., Ltd. from August 2017 to September 2023 [2] - He has been an external director at Haode Technology Co., Ltd. from February 2016 to June 2024 [2] - Currently, he serves as an independent non-executive director at China CITIC Limited and Wanwu Cloud Space Technology Service Co., Ltd. [2] Group 3: Contribution to Zhi Zi Cheng Technology - The board and the nomination committee of Zhi Zi Cheng Technology believe that Chen Yuyu's appointment will bring valuable perspectives, knowledge, skills, and experience to ensure the board operates efficiently and effectively [3]

呈交日期: 2025年9月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 09911 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 3,000,000,000 | USD | | 0.0001 | USD | | 300,000 | | 增加 / 減少 (-) | | | | | | | USD | | | | 本月底結存 | | | 3,000,000,000 | USD | | 0.0001 | USD | | 300,000 | 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | | | 致：香港交易及結算所有限公司 公司名稱: 赤子城科技有限公司 本月底法定/註冊股本總額： USD 300,000 FF301 ...

Core Viewpoint - The report from CICC indicates an upward revision of revenue forecasts for Zhizi City Technology (09911) for 2025 and 2026 by 2% to 6.9 billion and 8.5 billion respectively, driven by better-than-expected growth in innovative business [1] Group 1: Financial Performance - The company's 1H25 revenue increased by 40% to 3.18 billion, aligning with CICC's expectations [2] - Adjusted EBITDA for 1H25 rose by 44% to 650 million, while net profit attributable to shareholders surged by 118% to 490 million, meeting previous profit forecast medians [2] Group 2: Revenue Drivers - Social business revenue in 1H25 grew by 37% to 2.83 billion, driven by user growth and ARPU increase; innovative business saw a significant 71% year-on-year increase to 347 million [3] - Key products SUGO and TopTop achieved triple-digit year-on-year growth, contributing nearly 50% to the social revenue; SUGO's average online duration per user increased by 17% and ARPU by 20% [3] - The company is incubating 5-6 new flagship products, which are expected to contribute over 20% to social revenue, with several anticipated to reach monthly revenue scales of 10 million USD [3] Group 3: Market Expansion - In 1H25, over 60% of high ARPU revenue came from the Middle East and North Africa, with core products in this market seeing over 60% revenue growth; the company is also exploring opportunities in Latin America, Europe, and Japan [4] - CICC expects continued rapid growth in user scale for 2025, supporting a 34% increase in social business revenue [4] Group 4: Profitability and Cost Structure - The gross margin for 1H25 reached 56%, an increase of 6 percentage points, attributed to a decrease in revenue-sharing ratios in social business and an increase in high-margin innovative business [5] - The company anticipates that marketing costs for new products will remain high in the short term, but plans to enhance capabilities through centralized integration and AI empowerment, which is expected to gradually release operational leverage [5]

Core Viewpoint - The company reported a strong performance in 1H25, with revenue growth of 40% year-on-year, driven by robust social and innovative business segments [1] Revenue Performance - 1H25 revenue increased by 40% to 3.18 billion yuan, aligning with expectations; adjusted EBITDA rose by 44% to 650 million yuan, and net profit attributable to shareholders surged by 118% to 490 million yuan, slightly below expectations due to higher marketing expenses offsetting margin improvements [1] - Social business revenue grew by 37% to 2.83 billion yuan, driven by user growth and increased ARPU; innovative business saw a 71% increase to 347 million yuan, with expectations of profitability from premium games [1] Product Development - New flagship products are showing continuous revenue growth, contributing over 20% to social revenue, with several expected to reach monthly revenues of 10 million USD [2] - The content creation community Aippy is in testing, focusing on solidifying content and user base before exploring various monetization strategies [2] Market Expansion - The Middle East and North Africa market accounted for over 60% of high ARPU revenue, with core products seeing over 60% revenue growth; Southeast Asia remains stable, and the company is exploring opportunities in Latin America, Europe, and Japan [2] - The company anticipates continued rapid user growth in 2025, supporting a 34% increase in social business revenue [2] Margin and Cost Structure - 1H25 gross margin reached 56%, up 6 percentage points, due to a decrease in revenue share from social business and an increase in high-margin innovative business [2] - The company expects high marketing costs for new products to persist but aims to enhance operational efficiency through centralized integration and AI empowerment [2] Financial Forecast and Valuation - Revenue forecasts for 2025 and 2026 have been raised by 2% to 6.9 billion and 8.5 billion yuan, respectively, while net profit forecasts remain unchanged [2] - The company maintains an "outperform" rating, adjusting the target price by 20% to 13.5 HKD, indicating a 10% upside potential from the current stock price [2]